Growth momentum Inspire Medical Systems shows strong revenue performance with recent quarter results beating expectations and revenue around $269 million, indicating a solid market demand and potential for upsell of additional therapy components or services to expanding customer bases.

European expansion The European footprint is expanding significantly, now with over 80 employees to support therapy implementation and NHS adoption in England, signaling opportunity to partner with European distributors, integrate with local care pathways, and align with regional reimbursement strategies.

Competitive landscape Several competitors and potential rivals are gaining attention in the neurostimulation space, including LivaNova and Alphatec Spine, suggesting a need to accelerate value demonstrations, clinical outcomes data, and after-sales support to defend market share.

Finance and risk There are notable securities litigation concerns and prior governance-related issues, so sales teams should emphasize transparent customer onboarding, robust service levels, and compliance assurances when engaging new hospital systems or managed care networks.

Strategic partnerships With a substantial funding base and a broad tech stack, there are opportunities to collaborate on digital health integrations, data-driven outcomes tracking, and payer-focused value propositions that leverage the company’s FDA-cleared fully implanted system.